242 related articles for article (PubMed ID: 35861789)
1. Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis.
Belgers V; Röttgering JG; Douw L; Klein M; Ket JCF; van de Ven PM; Würdinger T; van Linde ME; Niers JM; Weber M; Olde Rikkert MG; Lopez-Sendon J; Arrieta O; Svendsen KB; Chagas MHN; de Almeida CMO; Kouwenhoven MCM; de Witt Hamer PC
Cannabis Cannabinoid Res; 2023 Feb; 8(1):41-55. PubMed ID: 35861789
[No Abstract] [Full Text] [Related]
2. Cannabis for the treatment of ulcerative colitis.
Kafil TS; Nguyen TM; MacDonald JK; Chande N
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012954. PubMed ID: 30406638
[TBL] [Abstract][Full Text] [Related]
3. Approved cannabinoids for medical purposes - Comparative systematic review and meta-analysis for sleep and appetite.
Spanagel R; Bilbao A
Neuropharmacology; 2021 Sep; 196():108680. PubMed ID: 34181977
[TBL] [Abstract][Full Text] [Related]
4. Cannabis for the treatment of Crohn's disease.
Kafil TS; Nguyen TM; MacDonald JK; Chande N
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012853. PubMed ID: 30407616
[TBL] [Abstract][Full Text] [Related]
5. Cannabis-based medicines for chronic neuropathic pain in adults.
Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis.
Velayudhan L; McGoohan K; Bhattacharyya S
PLoS Med; 2021 Mar; 18(3):e1003524. PubMed ID: 33780450
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids for fibromyalgia.
Walitt B; Klose P; Fitzcharles MA; Phillips T; Häuser W
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011694. PubMed ID: 27428009
[TBL] [Abstract][Full Text] [Related]
8. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).
Hardy J; Haywood A; Gogna G; Martin J; Yates P; Greer R; Good P
Trials; 2020 Jul; 21(1):611. PubMed ID: 32631447
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Safety and Tolerability of Natural and Synthetic Cannabinoids in Older Adults: A Systematic Review and Meta-Analysis of Open-Label Trials and Observational Studies.
Pisani S; McGoohan K; Velayudhan L; Bhattacharyya S
Drugs Aging; 2021 Oct; 38(10):887-910. PubMed ID: 34235645
[TBL] [Abstract][Full Text] [Related]
11. Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications.
Bilbao A; Spanagel R
BMC Med; 2022 Aug; 20(1):259. PubMed ID: 35982439
[TBL] [Abstract][Full Text] [Related]
12. Dosing of Cannabinoids Associated with an Opioid-Sparing Effect: A Systematic Review of Longitudinal Studies.
El-Mourad J; Lunghi C; Herrera NP; Zongo A
Pain Manag Nurs; 2024 Feb; 25(1):e8-e20. PubMed ID: 37689509
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies].
Petzke F; Enax-Krumova EK; Häuser W
Schmerz; 2016 Feb; 30(1):62-88. PubMed ID: 26830780
[TBL] [Abstract][Full Text] [Related]
14. A Systematic Review of Medical Cannabinoids Dosing in Human.
Campos DA; Mendivil EJ; Romano M; García M; Martínez ME
Clin Ther; 2022 Dec; 44(12):e39-e58. PubMed ID: 36411116
[TBL] [Abstract][Full Text] [Related]
15. How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review.
Hoch E; Niemann D; von Keller R; Schneider M; Friemel CM; Preuss UW; Hasan A; Pogarell O
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):87-105. PubMed ID: 30706168
[TBL] [Abstract][Full Text] [Related]
16. Safety and tolerability of escalating cannabinoid doses in healthy cats.
Kulpa JE; Paulionis LJ; Eglit GM; Vaughn DM
J Feline Med Surg; 2021 Dec; 23(12):1162-1175. PubMed ID: 33769105
[TBL] [Abstract][Full Text] [Related]
17. Technology-based and digital interventions for intimate partner violence: A systematic review and meta-analysis.
Emezue C; Chase JD; Udmuangpia T; Bloom TL
Campbell Syst Rev; 2022 Sep; 18(3):e1271. PubMed ID: 36909881
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids for the treatment of dementia.
Krishnan S; Cairns R; Howard R
Cochrane Database Syst Rev; 2009 Apr; 2009(2):CD007204. PubMed ID: 19370677
[TBL] [Abstract][Full Text] [Related]
19. Psychosocial interventions for preventing and treating depression in dialysis patients.
Natale P; Palmer SC; Ruospo M; Saglimbene VM; Rabindranath KS; Strippoli GF
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004542. PubMed ID: 31789430
[TBL] [Abstract][Full Text] [Related]
20. Exercise interventions on health-related quality of life for cancer survivors.
Mishra SI; Scherer RW; Geigle PM; Berlanstein DR; Topaloglu O; Gotay CC; Snyder C
Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD007566. PubMed ID: 22895961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
